- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
NGF Receptor Antibody Cocktail NGFR5 + NTR/912 recognizes a glycoprotein of 75kDa, identified as low affinity Nerve Growth Factor (NGF) Receptor (p75NGFR) or Neurotrophin Receptor (p75NTR). NGFR is expressed in various neural crest cells and their tumors such as melanocytes, melanomas, neuroblastomas, pheochromocytomas and neurofibromas. Reportedly, anti-NGFR is a reliable marker for desmoplastic and neurotropic melanomas. NGFR is expressed in mature non-neural cells such as perivascular cells, dental pulp cells, lymphoidal follicular dendritic cells, basal epithelium of oral mucosa and hair follicles, prostate basal cells, and myoepithelial cells. Anti-NGFR stains the myoepithelial cells of breast ducts and intra-lobular fibroblasts of breast ducts.
For an alternative antibody targeting the same neurotrophin receptor, see our NGFR Antibody NGFR/4919, a mouse monoclonal antibody featuring human melanoma IHC and protein microarray specificity validation.
Optimal dilution of the NGF Receptor Antibody Cocktail NGFR5 + NTR/912 should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
NGFR from A875 melanoma cells (NGFR5) and recombinant human protein (NTR/912) were used as the immunogen for the NGF Receptor Antibody Cocktail NGFR5 + NTR/912.
Store the NGF Receptor Antibody Cocktail NGFR5 + NTR/912 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
NGFR antibody, p75NTR antibody, TNFRSF16 antibody, NGF Receptor antibody, p75 NGF Receptor antibody, Low Affinity Nerve Growth Factor Receptor antibody, p75 Neurotrophin Receptor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.